Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Universities, Chugai Working on Cancer Treatment, Nikkei Says

Sept. 20 (Bloomberg) -- A research team including the University of Tokyo and Chugai Pharmaceutical Corp. has started developing a cancer treatment using antibodies and radiation, the Nikkei newspaper reported.

The members also including Fujifilm Holdings Corp. and Osaka University aim to develop treatments that reduce side effects to cure cancers of the colon, lungs, liver and pancreas, the newspaper reported without saying where it obtained the information. The group hopes to complete tests on animals within three years.

The drug will be designed by the University of Tokyo and Osaka University, and production will be handled by Chugai, the Nikkei said. Fujifilm will develop substances for radiation treatment, according to the report.

To contact the reporter on this story: Masumi Suga in Tokyo at msuga@bloomberg.net;

To contact the editor responsible for this story: Jonathan Annells at jannells@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.